Comparison of Effectiveness Among Different Sodium-Glucose Cotransporter-2 Inhibitors According to Underlying Conditions: A Network Meta-Analysis of Randomized Controlled Trials (vol 13, e031805, 2024)

被引:0
|
作者
Kani, Ryoma
机构
来源
关键词
D O I
10.1161/JAHA.123.027762
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Comparison of Effectiveness Among Different Sodium-Glucose Cotransoporter-2 Inhibitors According to Underlying Conditions: A Network Meta-Analysis of Randomized Controlled Trials
    Kani, Ryoma
    Watanabe, Atsuyuki
    Miyamoto, Yoshihisa
    Ejiri, Kentaro
    Iwagami, Masao
    Takagi, Hisato
    Slipczuk, Leandro
    Tsugawa, Yusuke
    Aikawa, Tadao
    Kuno, Toshiki
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2024, 13 (03):
  • [2] The effect of sodium-glucose cotransporter-2 inhibitors on inflammatory biomarkers: A meta-analysis of randomized controlled trials
    Buttice, Leonardo
    Ghani, Maryam
    Suthakar, Janahan
    Gnanalingham, Sathyan
    Carande, Elliott
    Kennedy, Brett W. C.
    Pitcher, Alex
    Gamble, James H. P.
    Ahmad, Mahmood
    Lewis, Andrew
    Juni, Peter
    Rider, Oliver J.
    Stephens, Jeffrey W.
    Bray, Jonathan J. H.
    DIABETES OBESITY & METABOLISM, 2024, 26 (07): : 2706 - 2721
  • [3] The impact of sodium-glucose Cotransporter-2 inhibitors on lipid profile: A meta-analysis of 28 randomized controlled trials
    Fan, Gang
    Guo, Dian long
    Zuo, Hong
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2023, 959
  • [4] Risk of hypovolemia associated with sodium-glucose cotransporter-2 inhibitors treatment: A meta-analysis of randomized controlled trials
    Rong, Xi
    Zhu, Yawen
    Wen, Bo
    Liu, Kai
    Li, Xinran
    Gou, Qiling
    Chen, Xiaoping
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [5] Sodium-glucose cotransporter-2 inhibitors and cancer outcomes: A systematic review and meta-analysis of randomized controlled trials
    Spiazzi, Bernardo F.
    Naibo, Rafaella A.
    Wayerbacher, Laura F.
    Piccoli, Giovana F.
    Farenzena, Laura P.
    Londero, Thiza M.
    da Natividade, Gabriella R.
    Zoldan, Maira
    Degobi, Nathalia A. H.
    Niches, Matheus
    Lopes, Gilberto
    Boyko, Edward J.
    Utzschneider, Kristina M.
    Colpani, Veronica
    Gerchman, Fernando
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2023, 198
  • [6] Sodium-Glucose Cotransporter-2 Inhibitors After Acute Myocardial Infarction: A Meta-analysis of Randomized Controlled Trials
    Ibrahim, Sammudeen
    Chinnatambi, Christopher
    Osman, Abdul-Fatawu
    Addo, Basilio
    Allihien, Saint-Martin
    Ozaeta, Jan Camille
    Kesiena, Onoriode
    Singireddy, Shreyas
    Amoateng, Richard
    Ahmed, Ibrahim
    CIRCULATION, 2024, 150
  • [7] Sodium-Glucose Cotransporter-2 Inhibitors in Heart Failure: A Meta-Analysis of Randomized Clinical Trials
    Kumar, Kris
    Kheiri, Babikir
    Simpson, Timothy F.
    Osman, Mohammed
    Rahmouni, Hind
    AMERICAN JOURNAL OF MEDICINE, 2020, 133 (11): : E625 - E630
  • [8] Comparison of sodium-glucose cotransporter-2 (SGLT2) inhibitors to reduce cardiovascular and renal outcomes: a network meta-analysis of randomized controlled trials
    Kani, R.
    Watanabe, A.
    Miyamoto, Y.
    Kuno, T.
    EUROPEAN HEART JOURNAL, 2023, 44
  • [9] Sodium-glucose cotransporter-2 inhibitors in acute myocardial infarction: a systematic review and meta-analysis of randomized controlled trials
    Meine, Matheus Coelho
    Santo, Paula
    de Oliveira, Fabiana Dolovitsch
    Marques, Gustavo Lenci
    Barboza, Joaquim Spadoni
    HEART FAILURE REVIEWS, 2025, 30 (01) : 219 - 226
  • [10] The effect of sodium-glucose cotransporter-2 inhibitors on cardiac structure remodeling and function: A meta-analysis of randomized controlled trials
    Fan, Gang
    Guo, Dian-Long
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2023, 114 : 49 - 57